MacroGenics | MGNX - Trade Creditors


MacroGenics reported $4.29M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Amgen USD 2.86B 16.65B Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Daiichi Sankyo JPY 539.05B 57.81B Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Genmab DKK 6M 2M Sep/2025
Geron USD 8.8M 3.92M Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
J&J USD 9.22B 1.24B Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Merck USD 3.86B 541M Mar/2026
Pfizer USD 4.58B 75M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026